vs
Side-by-side financial comparison of FONAR CORP (FONR) and Silvercrest Asset Management Group Inc. (SAMG). Click either name above to swap in a different company.
Silvercrest Asset Management Group Inc. is the larger business by last-quarter revenue ($32.0M vs $25.5M, roughly 1.3× FONAR CORP). FONAR CORP runs the higher net margin — 8.0% vs -0.4%, a 8.4% gap on every dollar of revenue. On growth, FONAR CORP posted the faster year-over-year revenue change (2.4% vs -0.0%). Silvercrest Asset Management Group Inc. produced more free cash flow last quarter ($15.0M vs $-227.0K). Over the past eight quarters, Silvercrest Asset Management Group Inc.'s revenue compounded faster (2.7% CAGR vs -0.3%).
FONAR Corp is a specialized medical technology firm that designs, manufactures, and distributes innovative MRI systems including upright and open models. It primarily serves U.S. hospitals, diagnostic imaging centers, and healthcare providers, delivering high-precision scanning solutions for clinical diagnostic use.
FONR vs SAMG — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.5M | $32.0M |
| Net Profit | $2.1M | $-120.0K |
| Gross Margin | — | — |
| Operating Margin | 13.5% | -2.8% |
| Net Margin | 8.0% | -0.4% |
| Revenue YoY | 2.4% | -0.0% |
| Net Profit YoY | 4.7% | -107.4% |
| EPS (diluted) | — | $0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.5M | $32.0M | ||
| Q3 25 | $26.0M | $31.3M | ||
| Q2 25 | $27.3M | $30.7M | ||
| Q1 25 | $27.2M | $31.4M | ||
| Q4 24 | $24.9M | $32.0M | ||
| Q3 24 | $25.0M | $30.4M | ||
| Q2 24 | $25.9M | $31.0M | ||
| Q1 24 | $25.7M | $30.3M |
| Q4 25 | $2.1M | $-120.0K | ||
| Q3 25 | $2.3M | $618.0K | ||
| Q2 25 | $729.3K | $1.9M | ||
| Q1 25 | $2.5M | $2.5M | ||
| Q4 24 | $2.0M | $1.6M | ||
| Q3 24 | $3.1M | $2.3M | ||
| Q2 24 | $830.4K | $2.7M | ||
| Q1 24 | $1.9M | $3.0M |
| Q4 25 | 13.5% | -2.8% | ||
| Q3 25 | 14.1% | 4.3% | ||
| Q2 25 | 5.3% | 13.2% | ||
| Q1 25 | 15.2% | 15.4% | ||
| Q4 24 | 11.9% | 6.1% | ||
| Q3 24 | 21.0% | 14.6% | ||
| Q2 24 | 7.4% | 17.1% | ||
| Q1 24 | 16.8% | 19.5% |
| Q4 25 | 8.0% | -0.4% | ||
| Q3 25 | 8.7% | 2.0% | ||
| Q2 25 | 2.7% | 6.3% | ||
| Q1 25 | 9.2% | 7.9% | ||
| Q4 24 | 7.9% | 5.1% | ||
| Q3 24 | 12.6% | 7.4% | ||
| Q2 24 | 3.2% | 8.6% | ||
| Q1 24 | 7.3% | 9.9% |
| Q4 25 | — | $0.02 | ||
| Q3 25 | — | $0.07 | ||
| Q2 25 | — | $0.21 | ||
| Q1 25 | — | $0.26 | ||
| Q4 24 | — | $0.16 | ||
| Q3 24 | — | $0.24 | ||
| Q2 24 | — | $0.28 | ||
| Q1 24 | — | $0.32 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $121.0K | $44.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $176.9M | $50.3M |
| Total Assets | $217.2M | $166.6M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $121.0K | $44.1M | ||
| Q3 25 | $122.0K | $36.1M | ||
| Q2 25 | $56.5M | $30.0M | ||
| Q1 25 | $123.0K | $36.3M | ||
| Q4 24 | $121.0K | $68.6M | ||
| Q3 24 | $136.0K | $58.1M | ||
| Q2 24 | $56.5M | $49.9M | ||
| Q1 24 | $134.0K | $39.7M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | $66.9K | — | ||
| Q1 24 | — | — |
| Q4 25 | $176.9M | $50.3M | ||
| Q3 25 | $174.9M | $58.9M | ||
| Q2 25 | $172.6M | $64.6M | ||
| Q1 25 | $171.9M | $80.0M | ||
| Q4 24 | $169.8M | $80.7M | ||
| Q3 24 | $168.7M | $84.6M | ||
| Q2 24 | $166.0M | $85.3M | ||
| Q1 24 | $165.8M | $83.9M |
| Q4 25 | $217.2M | $166.6M | ||
| Q3 25 | $218.4M | $157.6M | ||
| Q2 25 | $216.9M | $152.7M | ||
| Q1 25 | $214.9M | $159.9M | ||
| Q4 24 | $208.0M | $194.4M | ||
| Q3 24 | $212.3M | $184.2M | ||
| Q2 24 | $214.2M | $177.6M | ||
| Q1 24 | $209.6M | $170.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.00× | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $171.0K | $18.6M |
| Free Cash FlowOCF − Capex | $-227.0K | $15.0M |
| FCF MarginFCF / Revenue | -0.9% | 46.9% |
| Capex IntensityCapex / Revenue | 1.6% | 11.4% |
| Cash ConversionOCF / Net Profit | 0.08× | — |
| TTM Free Cash FlowTrailing 4 quarters | $5.7M | $17.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $171.0K | $18.6M | ||
| Q3 25 | $1.7M | $14.6M | ||
| Q2 25 | $4.2M | $13.8M | ||
| Q1 25 | $3.1M | $-24.7M | ||
| Q4 24 | $2.2M | $21.6M | ||
| Q3 24 | $1.7M | $13.3M | ||
| Q2 24 | $4.6M | $16.0M | ||
| Q1 24 | $2.8M | $-24.1M |
| Q4 25 | $-227.0K | $15.0M | ||
| Q3 25 | $-177.0K | $13.8M | ||
| Q2 25 | $3.6M | $13.4M | ||
| Q1 25 | $2.6M | $-25.1M | ||
| Q4 24 | $1.5M | $19.9M | ||
| Q3 24 | $-148.0K | $12.9M | ||
| Q2 24 | $4.2M | $15.6M | ||
| Q1 24 | $2.6M | $-24.7M |
| Q4 25 | -0.9% | 46.9% | ||
| Q3 25 | -0.7% | 44.1% | ||
| Q2 25 | 13.1% | 43.6% | ||
| Q1 25 | 9.4% | -80.0% | ||
| Q4 24 | 6.0% | 62.2% | ||
| Q3 24 | -0.6% | 42.4% | ||
| Q2 24 | 16.1% | 50.4% | ||
| Q1 24 | 10.2% | -81.6% |
| Q4 25 | 1.6% | 11.4% | ||
| Q3 25 | 7.2% | 2.6% | ||
| Q2 25 | 2.4% | 1.5% | ||
| Q1 25 | 2.2% | 1.3% | ||
| Q4 24 | 3.0% | 5.3% | ||
| Q3 24 | 7.2% | 1.2% | ||
| Q2 24 | 1.6% | 1.1% | ||
| Q1 24 | 0.7% | 2.0% |
| Q4 25 | 0.08× | — | ||
| Q3 25 | 0.75× | 23.62× | ||
| Q2 25 | 5.79× | 7.22× | ||
| Q1 25 | 1.26× | -10.01× | ||
| Q4 24 | 1.14× | 13.34× | ||
| Q3 24 | 0.53× | 5.90× | ||
| Q2 24 | 5.54× | 6.00× | ||
| Q1 24 | 1.50× | -8.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FONR
| Managementof Diagnostic Imaging Centers | $23.2M | 91% |
| Manufacturingand Servicingof Medical Equipment | $2.4M | 9% |
SAMG
| Investment Advisory Management And Administrative Service | $30.7M | 96% |
| Tax And Family Office Services | $1.2M | 4% |
